切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - DREADD Ligands - ULK1 - Ksp - Inward Rectifier Potassium (Kir) Channels

10 件产品

每页
清除全部
  1. SBI-0206965
    A8715 SBI-0206965
     2 Citation
    Target: ULK1
    Summary: ULK1抑制剂
      ≥24.47 mg/mL
      insoluble in H2O
  2. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  3. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  4. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  5. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  6. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  7. Ispinesib (SB-715992)
    A5343 Ispinesib (SB-715992)
    中文名: 伊斯平斯
    Target: Ksp
    Summary: 驱动蛋白纺锤体蛋白(KSP)抑制剂
      ≥25.85 mg/mL
      insoluble in H2O
  8. Clozapine N-oxide(CNO)
    A3317 Clozapine N-oxide(CNO)
     1 Citation
    中文名: 氯氮平的N-氧化物
    Target: DREADD Ligands
    Summary: Clozapine代谢产物,用于化学遗传学
      ≥17.15 mg/mL
      ≥49 mg/mL
  9. ARRY-520 R enantiomer
    A3188 ARRY-520 R enantiomer
    Target: Ksp
    Summary: KSP抑制剂
      Soluble in DMSO
  10. Glimepiride
    A4033 Glimepiride
    中文名: 格列美脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 磺酰脲类化合物
      ≥21.45 mg/mL
      insoluble in H2O

10 件产品

每页